|
|
|||
|
||||
OverviewFull Product DetailsAuthor: James M. GoldfarbPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: Softcover reprint of the original 1st ed. 2014 Dimensions: Width: 17.80cm , Height: 1.30cm , Length: 25.40cm Weight: 4.728kg ISBN: 9781493944040ISBN 10: 1493944045 Pages: 234 Publication Date: 23 August 2016 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsMedical Implications of Oocyte Donation.- Oocyte Donation: Legal Aspects.- Oocyte Donation: Psychological Aspects.- Oocyte Donation: Ethical Aspects.- Gestational Carrier: Medical Aspects.- Surrogacy and Gestational Carrier Arrangements: Legal Aspects.- Use of Gestational Carriers: Psychological Aspects.- The Ethics of Hiring a Gestational Carrier.- Embryo Donation: Medical Aspects.- Embryo Donation: Legal Aspects.- Embryo Donation: Psychological Aspects.- Embryo Donation: Ethical Issues.- Donor Insemination.- Sperm Donation: Legal Aspects.- Sperm Donation: Psychological Aspects.- Sperm Donation: Ethical Aspects.- Medical Aspects of Posthumous Reproduction.- Ethical Implications of Posthumous Reproduction.- Hagar’s Child: Theology, Ethics, and the Third Party in Emerging Reproductive Technology.- Choosing Egg Donors and Gestational Carriers: Avoiding the Pitfalls.ReviewsAuthor InformationJames Goldfarb, MD, MBA, is the Director of Fertility Services and In Vitro Fertilization at University Hospitals of Cleveland. He is also a Clinical Professor of Reproductive Biology at the Lerner College of Medicine of Case Western Reserve University. Since the 80's, Dr. Goldfarb has been at the forefront of third party reproduction. His infertility program was responsible for the first in-vitro fertilization birth in Ohio in 1983 and the world's first in-vitro fertilization/surrogate birth in 1986. He is immediate past president of the Society for Assisted Reproductive Technologies (SART) and, through his association with SART and his active clinical practice, he has been very involved with recent issues regarding all aspects of third party reproduction. Tab Content 6Author Website:Countries AvailableAll regions |